Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
KingsRock Advisors Announces Additional ten Senior Hires, including Wilder Fulford in M&A and Healthcare
GlobeNewswire, Inc.
NEW YORK and LONDON and STOCKHOLM and DUBAI, United Arab Emirates and MUMBAI, India, June 15, 2026 (GLOBE NEWSWIRE) -- KingsRock Advisors, LLC, an independent global advisory firm, announced today the continuation of its growth, with a series of...
Ascendis to Showcase Advances in Treatment of Rare Endocrine Diseases at ENDO 2026
GlobeNewswire, Inc.
COPENHAGEN, Denmark, June 08, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the latest data from its Endocrinology Rare Disease programs in hypoparathyroidism, achondroplasia, and pediatric growth hormone...
Zealand Pharma announces Boehringer Ingelheim's survodutide Phase III trial in people living with obesity showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis
GlobeNewswire, Inc.
Company announcement No. 21 / 2026 Zealand Pharma announces Boehringer Ingelheim's survodutide Phase III trial showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis, supporting improved...
Zealand Pharma - Transactions related to share buy-back program (week 23, 2026)
GlobeNewswire, Inc.
Company announcement No. 23 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 23, 2026) Copenhagen, Denmark, June 8, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a...
Zealand Pharma increases its share capital as a result of the exercise of employee warrants
GlobeNewswire, Inc.
Company announcement – No. 22 / 2026 Zealand Pharma increases its share capital as a result of the exercise of employee warrants Copenhagen, Denmark, June 8, 2026 – Zealand Pharma A/S (“Zealand Pharma”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a...
Kyowa Kirin to Present New Complementary Evidence Further Defining Clinical Utility of Mogamulizumab in Cutaneous T-Cell Lymphoma at 2026 WCCL
GlobeNewswire, Inc.
PRINCETON, N.J., June 10, 2026 (GLOBE NEWSWIRE) -- Kyowa Kirin, Inc., a wholly owned subsidiary of Kyowa Kirin Co. Ltd (TSE: 4151), today announced new data further defining the potential of mogamulizumab in the treatment of relapsed or refractory...
Casein and Caseinate Market Expands to US$6.2 Bn Driven by Sports Nutrition
EIN Presswire
The casein and caseinate market is projected to grow steadily from US$ 3.8 Bn in 2026 to US$ 6.2 Bn by 2033, registering a CAGR of 5.6% overall LONDON, LONDON, UNITED KINGDOM, June 11, 2026 /EINPresswire.com/ -- The global casein and caseinate...
Christian Eriksen Falls Ill During Denmark Match, Play Halted
MENAFN
(MENAFN) Danish footballer Christian Eriksen collapsed during an international match between Denmark and Ukraine on Sunday, leading to an immediate medical response and the suspension of play, according to reports.
Eriksen Collapses on Pitch During Denmark vs Ukraine Match
MENAFN
(MENAFN) Danish football star Christian Eriksen collapsed during Denmark's international match against Ukraine on Sunday, triggering an immediate medical response and the suspension of play in scenes that drew instant comparisons to the...
Cosmos Health Achieves Pan-European Distribution for Sky Premium Life Across All 27 EU Member States Through Leading E-Commerce Platform Skroutz
GlobeNewswire, Inc.
CHICAGO, June 04, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that its proprietary brand, Sky Premium Life, is now...
Agricultural Microbials Market to Reach USD 21.47 Billion by 2031, at a CAGR of 13.4% — MarketsandMarkets™
GlobeNewswire, Inc.
Delray Beach, FL, Aug. 26, 2026 (GLOBE NEWSWIRE) -- MarketsandMarkets™ estimates that the global agricultural microbials market will grow from USD 11.43 billion in 2026 to USD 21.47 billion by 2031, registering a CAGR of 13.4%. Growth is driven by...
Zealand Pharma to participate in the Goldman Sachs Global Healthcare Conference
GlobeNewswire, Inc.
Press release – No. 12 / 2026 Zealand Pharma to participate in the Goldman Sachs Global Healthcare Conference Copenhagen, Denmark, June 2, 2026 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company transforming the future...
Zealand Pharma - Transactions related to share buy-back program (week 22, 2026)
GlobeNewswire, Inc.
Company announcement No. 20 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 22, 2026) Copenhagen, Denmark, June 1, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a...
Knight Therapeutics Announces Launch of WYNZORA® in Canada
GlobeNewswire, Inc.
MONTREAL, Aug. 20, 2026 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. ("Knight") (TSX: GUD), a pan-American (ex-US) pharmaceutical company, announced today the launch of WYNZORA®, a uniform white aqueous cream containing 0.05 mg/g of calcipotriol...
Enable Me Highlights Heavy-Duty Mobility Chairs for Bariatric Independence
EIN Presswire
The VELA Epic Independence Chairs provide stable, ergonomic support for adults up to 660 lbs, ensuring safe indoor mobility and all-day comfort.
World Bicycle Day: Experience Denmark through Danish Wheelness™
GlobeNewswire, Inc.
Copenhagen, May 28, 2026 (GLOBE NEWSWIRE) -- In Denmark, cycling is much more than a means of transport.
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
GlobeNewswire, Inc.
Company announcement – No. 19 / 2026 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, May 29, 2026 – Zealand Pharma A/S...
H1 2026: Novonesis delivered strong 8% organic sales growth and increases full-year outlook
GlobeNewswire, Inc.
COPENHAGEN, Denmark – August 19, 2026. Novonesis delivered strong first half of 2026 at 8% organic sales growth. 2026 outlook: Organic sales growth increased to 7-8% (previously 5-7%), and the adjusted EBITDA margin expected at the higher end of...
Zealand Pharma to Present Data at the American Diabetes Association's 2026 Scientific Sessions
GlobeNewswire, Inc.
Press release – No. 10 / 2026 Zealand Pharma to Present Data at the American Diabetes Association's 2026 Scientific Sessions Late-breaking Phase 2 ZUPREME-1 data on petrelintide to be featured as ePoster Theater presentation and poster sessions...
Zealand Pharma to participate in the Jefferies Global Healthcare Conference
GlobeNewswire, Inc.
Press release – No. 11 / 2026 Zealand Pharma to participate in the Jefferies Global Healthcare Conference Copenhagen, Denmark, May 27, 2026 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company transforming the future of...
Sign up for:
Healthcare Times Denmark
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.